EX-13.1 4 f20f2022a2ex13-1_meihua.htm CERTIFICATION

Exhibit 13.1

 

Certification by the Principal Executive Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the amendment to the annual report of Meihua International Medical Technologies Co., Ltd. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Xin Wang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 21, 2023

 
   
By: /s/ Xin Wang  
Name:   Xin Wang  
Title: Chief Executive Officer
(Principal Executive Officer)